Peter Hu

1.1k total citations
20 papers, 735 citations indexed

About

Peter Hu is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Peter Hu has authored 20 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Peter Hu's work include Multiple Myeloma Research and Treatments (6 papers), Gastroesophageal reflux and treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Peter Hu is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Gastroesophageal reflux and treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Peter Hu collaborates with scholars based in United States, United Kingdom and Spain. Peter Hu's co-authors include Philip Raskin, Priscilla Hollander, Robert A. Gabbay, Bruce W. Bode, Andrew Lewin, Elsie Allen, Alan J. Garber, J. Curtis Nickel, Sender Herschorn and Andrew J. Friedman and has published in prestigious journals such as Blood, Diabetes Care and Clinical Cancer Research.

In The Last Decade

Peter Hu

20 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hu United States 10 436 174 151 122 61 20 735
Katalin Rajczy Hungary 15 152 0.3× 169 1.0× 79 0.5× 234 1.9× 4 0.1× 54 705
Samuel M. Mahaffey United States 12 36 0.1× 166 1.0× 212 1.4× 103 0.8× 14 0.2× 17 716
Conny Bürk Germany 9 118 0.3× 132 0.8× 37 0.2× 31 0.3× 22 0.4× 18 391
Isaac S. Engelberg Israel 11 31 0.1× 101 0.6× 112 0.7× 20 0.2× 19 0.3× 16 669
Patricia K. Heath United Kingdom 10 24 0.1× 178 1.0× 56 0.4× 536 4.4× 38 0.6× 11 838
Anja Bauerfeind Germany 12 37 0.1× 68 0.4× 163 1.1× 47 0.4× 3 0.0× 28 588
Henrik Gjertsen Sweden 14 35 0.1× 223 1.3× 174 1.2× 143 1.2× 5 0.1× 28 766
Ahmet A. Balık Türkiye 16 18 0.0× 543 3.1× 100 0.7× 29 0.2× 48 0.8× 42 766
Peter Royce Australia 15 36 0.1× 297 1.7× 109 0.7× 77 0.6× 231 3.8× 35 791
Madhu Mati Goel India 13 43 0.1× 190 1.1× 86 0.6× 10 0.1× 22 0.4× 65 461

Countries citing papers authored by Peter Hu

Since Specialization
Citations

This map shows the geographic impact of Peter Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hu more than expected).

Fields of papers citing papers by Peter Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hu. The network helps show where Peter Hu may publish in the future.

Co-authorship network of co-authors of Peter Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hu. A scholar is included among the top collaborators of Peter Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hu. Peter Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Brooke E., Andrew J. Armstrong, Johann S. de Bono, et al.. (2022). Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302. European Journal of Cancer. 170. 296–304. 20 indexed citations
2.
Jones, Robin L., Thomas J. Herzog, Shreyaskumar Patel, et al.. (2021). Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Medicine. 10(11). 3565–3574. 10 indexed citations
3.
Baciarello, Giulia, Mustafa Özgüroğlu, Suneel Mundle, et al.. (2021). Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE study. European Journal of Cancer. 162. 56–64. 21 indexed citations
4.
He, Jianming, Rian Van Rampelbergh, Lugui Qiu, et al.. (2020). Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study. Advances in Therapy. 38(1). 640–659. 8 indexed citations
5.
Parasrampuria, Dolly A., Jianming He, Liping Zhang, et al.. (2020). Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis. British Journal of Haematology. 189(5). 860–868. 2 indexed citations
6.
Mateos, María‐Victoria, Jesús F. San Miguel, Hartmut Goldschmidt, et al.. (2019). The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma. 61(3). 680–690. 7 indexed citations
7.
Leitz, G, Peter Hu, Qing Li, et al.. (2019). Safety and Efficacy of Low‐dose Domperidone for Treating Nausea and Vomiting Due to Acute Gastroenteritis in Children. Journal of Pediatric Gastroenterology and Nutrition. 69(4). 425–430. 5 indexed citations
8.
Brighton, Timothy, Amit Khot, Simon J. Harrison, et al.. (2019). Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma. Clinical Cancer Research. 25(13). 3772–3775. 55 indexed citations
9.
Miguel, Jesús F. San, María‐Victoria Mateos, Hartmut Goldschmidt, et al.. (2018). Impact of Modified Dose Schedule of Bortezomib, Melphalan, and Prednisone (VMP) for Previously Untreated, Transplant-Ineligible Patients with Multiple Myeloma (MM): A Matching-Adjusted Indirect Comparison. Blood. 132(Supplement 1). 3553–3553. 2 indexed citations
10.
11.
12.
Zhao, Ming, et al.. (2017). Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.. PubMed. 47(5). 523–528. 8 indexed citations
13.
14.
Nickel, J. Curtis, Sender Herschorn, Kristene Whitmore, et al.. (2014). Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study. The Journal of Urology. 193(3). 857–862. 84 indexed citations
15.
Hussain, Sunny Z., et al.. (2013). Safety and Efficacy of Delayed Release Rabeprazole in 1‐ to 11‐Month‐Old Infants With Symptomatic GERD. Journal of Pediatric Gastroenterology and Nutrition. 58(2). 226–236. 19 indexed citations
16.
Kierkuś, Jarosław, et al.. (2013). Efficacy and Safety of Rabeprazole in Children (1–11 Years) With Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition. 57(6). 798–807. 16 indexed citations
17.
Kierkuś, Jarosław, et al.. (2013). Maintenance of Efficacy and Safety of Rabeprazole in Children With Endoscopically Proven GERD. Journal of Pediatric Gastroenterology and Nutrition. 58(4). 510–517. 11 indexed citations
18.
Hu, Peter, Chang Woo Lee, Jing Xu, et al.. (2011). Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.. PubMed. 41(4). 321–30. 4 indexed citations
19.
Morrison, Richard N., Juan C. Sarria, Janak A. Patel, et al.. (2008). HIV-1 Genotypic Resistance Testing on Low Viral Load Specimens Using the Abbott ViroSeq HIV-1 Genotyping System. Laboratory Medicine. 39(11). 671–673. 5 indexed citations
20.
Raskin, Philip, Elsie Allen, Priscilla Hollander, et al.. (2005). Initiating Insulin Therapy in Type 2 Diabetes. Diabetes Care. 28(2). 260–265. 432 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katalin Rajczy Breakdown of academic impact, for papers by Samuel M. Mahaffey Breakdown of academic impact, for papers by Conny Bürk Breakdown of academic impact, for papers by Isaac S. Engelberg Breakdown of academic impact, for papers by Patricia K. Heath Breakdown of academic impact, for papers by Anja Bauerfeind Breakdown of academic impact, for papers by Henrik Gjertsen Breakdown of academic impact, for papers by Ahmet A. Balık Breakdown of academic impact, for papers by Peter Royce Breakdown of academic impact, for papers by Madhu Mati Goel
Rankless by CCL
2026